| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,764 |
12,341 |
$551K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,952 |
11,385 |
$492K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,812 |
4,550 |
$177K |
| 80053 |
Comprehensive metabolic panel |
15,631 |
14,653 |
$143K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,369 |
1,301 |
$117K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,943 |
3,646 |
$115K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,391 |
5,121 |
$92K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,631 |
1,588 |
$71K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,822 |
15,747 |
$68K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,759 |
3,506 |
$66K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,039 |
987 |
$66K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
598 |
579 |
$58K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,077 |
4,549 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
762 |
725 |
$47K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
863 |
802 |
$44K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
117 |
116 |
$43K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
368 |
364 |
$33K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,372 |
749 |
$30K |
| 84484 |
|
3,825 |
3,377 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
4,665 |
4,435 |
$29K |
| 84703 |
|
1,886 |
1,811 |
$17K |
| 83690 |
|
2,203 |
2,114 |
$15K |
| 97597 |
|
121 |
66 |
$12K |
| 81001 |
|
3,366 |
3,222 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
744 |
716 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
419 |
396 |
$7K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
116 |
115 |
$6K |
| G0378 |
Hospital observation service, per hour |
50 |
22 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
319 |
311 |
$4K |
| 82805 |
|
346 |
328 |
$4K |
| 83605 |
|
565 |
517 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
83 |
80 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
417 |
399 |
$3K |
| 85610 |
|
822 |
787 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
62 |
62 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
243 |
228 |
$2K |
| 83880 |
|
168 |
166 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
29 |
26 |
$2K |
| 81003 |
|
1,831 |
1,753 |
$2K |
| 83735 |
|
324 |
309 |
$2K |
| 87400 |
|
84 |
83 |
$1K |
| 87486 |
|
116 |
115 |
$1K |
| 87581 |
|
116 |
115 |
$1K |
| 80143 |
|
94 |
86 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
88 |
81 |
$975.76 |
| 87634 |
|
13 |
13 |
$856.86 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
62 |
62 |
$843.11 |
| 80179 |
|
64 |
57 |
$790.85 |
| 87077 |
|
65 |
61 |
$599.19 |
| 96376 |
|
21 |
14 |
$588.44 |
| 87040 |
|
41 |
40 |
$481.09 |
| 85730 |
|
124 |
118 |
$468.32 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,727 |
2,366 |
$444.24 |
| 87081 |
|
57 |
55 |
$419.08 |
| 85379 |
|
48 |
41 |
$351.60 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
14 |
14 |
$315.75 |
| 80320 |
|
26 |
24 |
$298.85 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
789 |
702 |
$294.39 |
| 84145 |
|
12 |
12 |
$241.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
403 |
379 |
$239.35 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$196.67 |
| 87186 |
|
12 |
12 |
$185.77 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20 |
20 |
$184.68 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
65 |
56 |
$165.55 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$159.87 |
| 85027 |
|
16 |
12 |
$159.57 |
| A0425 |
Ground mileage, per statute mile |
3,997 |
3,331 |
$108.64 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
207 |
195 |
$68.36 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
109 |
103 |
$54.86 |
| 36415 |
Collection of venous blood by venipuncture |
2,212 |
2,048 |
$52.65 |
| 84100 |
|
14 |
13 |
$50.76 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
12 |
12 |
$38.86 |
| A9270 |
Non-covered item or service |
323 |
230 |
$25.29 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
30 |
29 |
$21.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$11.85 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
338 |
329 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
88 |
84 |
$0.00 |
| 82077 |
|
69 |
67 |
$0.00 |